c
Cat. #
Product
Qty.
US $

(1R)-(+)-Camphanic Acid
((1R)-3-Oxo-4,7,7-trimethyl-2-oxabicyclo[2.2.1]heptane-1-carboxylic acid)
[67111-66-4]    C10H14O4    FW 198.22
250
mg
55.00
1
g
150.00
5
g
450.00

(1S)-(−)-Camphanic Acid, ≥98%
((1S)-3-Oxo-4,7,7-trimethyl-2-oxabicyclo[2.2.1]heptane-1-carboxylic acid)
[13429-83-9]    C10H14O4    FW 198.22
1
g
21.00
5
g
58.00
25
g
200.00

(1S)-(−)-Camphanic Acid, ≥99% (GC)
((1S)-3-Oxo-4,7,7-trimethyl-2-oxabicyclo[2.2.1]heptane-1-carboxylic acid)
[13429-83-9]    C10H14O4    FW 198.22
1
g
30.00
5
g
75.00
25
g
375.00

(1R)-(+)-Camphanoyl chloride
((1R)-3-Oxo-4,7,7-trimethyl-2-oxabicyclo[2.2.1]heptane-1-carboxyl chloride)
[104530-16-7]    C10H13ClO3    FW 216.66

(1S)-(−)-Camphanoyl chloride, ≥98% (GC)
((1S)-3-Oxo-4,7,7-trimethyl-2-oxabicyclo[2.2.1]heptane-1-carboxyl chloride)
[39637-74-6]    C10H13ClO3    FW 216.66
1
g
21.00
5
g
75.00
25
g
250.00

(+)-D-Camphor
((1R)-Camphor)
[464-49-3]    C10H16O    FW 152.23

(−)-L-Camphor
((1S)-Camphor)
[464-48-2]    C10H16O    FW 152.23
5
g
30.00
25
g
110.00
100
g
295.00

D-(+)-Camphoric acid, ≥99% (T)
((1R,3S)-Camphoric acid; (1R,3S)-1,2,2-Trimethyl-1,3-cyclopentanedicarboxylic acid)
[124-83-4]    C10H16O4    FW 200.23
Chiral building block, reduction to the diol: I. Kitagawa, et al., Chem. Pharm. Bull. 1981, 29, 2540, E.D. Longton, et al., J. Org. Chem. 1987 52, 933, K. Weinges, W. Sipos, Chem. Ber. 1988 121, 363. Synthesis of phenylcamphoric acid from the anhydride: R.T. Jacobs, et al., J. Org. Chem. 1990 55, 4051.
50
g
21.00
250
g
70.00
1
kg
200.00

D-(+)-Camphoric acid, ≥99% (T,GC) ≥99% e.e.
((1R,3S)-Camphoric acid; (1R,3S)-1,2,2-Trimethyl-1,3-cyclopentanedicarboxylic acid)
[124-83-4]    C10H16O4    FW 200.23
Chiral building block, reduction to the diol: I. Kitagawa, et al., Chem. Pharm. Bull. 1981, 29, 2540, E.D. Longton, et al., J. Org. Chem. 1987 52, 933, K. Weinges, W. Sipos, Chem. Ber. 1988 121, 363. Synthesis of phenylcamphoric acid from the anhydride: R.T. Jacobs, et al., J. Org. Chem. 1990 55, 4051.
50
g
34.00
250
g
105.00
1
kg
295.00

L-(−)-Camphoric acid
((1S,3R)-Camphoric acid; (1S,3R)-1,2,2-Trimethyl-1,3-cyclopentanedicarboxylic acid)
[560-09-8]    C10H16O4    FW 200.23
500
mg
39.00
2.5
g
135.00
10
g
375.00

(1R)-(−)-Camphorquinone
((−)-Bornanedione)
[10334-26-6]

(1S)-(+)-Camphorquinone
((1S)-Bornanedione)
[2767-84-2]

(1R,E)-(+)-Camphorquinone 3-oxime
([1R-(1α,3E,4α)]-1,7,7-Trimethylbicyclo[2.2.1]heptane-2,3-dione 3-oxime)
[31571-14-9]    C10H15NO2

(1S,E)-(−)-Camphorquinone 3-oxime
(anti-(1S)-Camphorquinone 3-oxime)
[251645-83-7]    C10H15NO2

(R)-10-Camphorsulfonamide, ≥97%
[72597-34-3]    C10H15NO2S    FW 213.30
1
g
24.00
5
g
85.00
25
g
275.00

(1S)-10-Camphorsulfonamide, ≥97%
[60933-63-3]    C10H17NO3S    FW 231.31
1
g
20.00
5
g
60.00
25
g
195.00

D-(+)-Camphorsulfonic acid, ≥99%
((1S)-β-Camphor-10-sulfonic acid; (1S,4R)-2-Oxo-10-bornanesulfonic acid; (S)-7,7-Dimethyl-2-oxobicyclo[2.2.1]heptane-1-methanesulfonic acid; D-Reychler's acid)
[3144-16-9]    C10H16O4S    FW 232.30
100
g
35.00
500
g
105.00
2.5
kg
315.00

L-(−)-10-Camphorsulfonic acid, ≥99%
((1R)-β-Camphorsulfonic acid; (1R,4S)-2-Oxo-10-bornanesulfonic acid; (R)-7,7-Dimethyl-2-oxobicyclo[2.2.1]heptane-1-methanesulfonic acid)
[35963-20-3]    C10H16O4S    FW 232.30

(R)-Camphorsulfonic acid diisopropylamide
C16H29NO3S    FW 315.47

(1S)-(+)-Camphorsulfonic acid diisopropylamide
((1S,4R)-N,N-Diisopropyl-7,7-dimethyl-2-oxo-bicyclo[2.2.1]heptane-1-methanesulfonamide; (+)-N,N-Diisopropyl-10-camphorsulfonamide; (+)-10-Diisopropylaminosulfonylcamphor)
[96323-05-6]    C16H29NO3S    FW 315.47

(R)-Camphorsulfonic acid diisopropylamide dimethyl acetal
C18H35NO4S    FW 361.54

(S)-Camphorsulfonic acid diisopropylamide dimethyl acetal
C18H35NO4S    FW 361.54

(R)-Camphorsulfonic acid diisopropylamide glycolate acetal

(S)-(−)-Camphorsulfonic acid diisopropylamide glycolate acetal
([1S-(1α,2α,4β)]-N,N-Diisopropyl-7,7-dimethyl-4′-oxospiro[bicyclo[2.2.1]heptane-2,2′-[1,3]dioxolane]-1-methanesulfonamide)
[163182-10-3]

(R)-Camphorsulfonic acid diisopropylamide lactate acetal

(S)-Camphorsulfonic acid diisopropylamide lactate acetal

(R)-Camphorsulfonic acid diisopropylamide mandelate acetal

(S)-Camphorsulfonic acid diisopropylamide mandelate acetal

(1R)-(+)-Camphorsulfonylimine, ≥98.5%
((7R)-10,10-Dimethyl-3-thia-4-azatricyclo[5.2.1.01,5]dec-4-ene-3,3-dioxide; (3aR)-4,5,6,7-tetrahydro-8,8-dimethyl-3H-3a,6-methano-2,1-benzisothiazole-2,2-dioxide)
[107869-45-4]    C10H15NO2S    FW 213.30

(1S)-(−)-Camphorsulfonylimine
((7S)-10,10-Dimethyl-3-thia-4-azatricyclo[5.2.1.01,5]dec-4-ene-3,3-dioxide; (3aS)-4,5,6,7-tetrahydro-8,8-dimethyl-3H-3a,6-methano-2,1-benzisothiazole-2,2-dioxide)
[60886-80-8]    C10H15NO2S    FW 213.30
1
g
18.00
5
g
70.00

(1S)-(−)-Camphorsulfonylimine, ≥98%
((7S)-10,10-Dimethyl-3-thia-4-azatricyclo[5.2.1.01,5]dec-4-ene-3,3-dioxide; (3aS)-4,5,6,7-tetrahydro-8,8-dimethyl-3H-3a,6-methano-2,1-benzisothiazole-2,2-dioxide)
[60886-80-8]    C10H15NO2S    FW 213.30

(1R)-(−)-(10-Camphorsulfonyl)oxaziridine
((R)-2,N-Epoxy-exo-10,2-bornanesultam)
[104372-31-8]    C10H15NO3S    FW 229.30
Chiral reagent for the asymmetric hydroxylation of carbanions, F.A. Davies et al. J. Org. Chem. 1992 57, 6387.

(1S)-(+)-(10-Camphorsulfonyl)oxaziridine
((S)-2,N-Epoxy-exo-10,2-bornanesultam)
[104322-63-6]    C10H15NO3S    FW 229.30

(−)-D-2,10-Camphorsultam, ≥98.5%
((1S)-2,10-Camphorsultam; (−)-exo-10,2-Bornanesultam; (1S,5R)-10,10-Dimethyl-3-thia-4-azatricyclo[5.2.1.01,5]decane 3,3-dioxide; [3aS-(3aα,6α,7aβ)]-Hexahydro-8,8-dimethyl-3H-3a,6-methano-2,1-benzisothiazole-2,2-dioxide)
[94594-90-8]    C10H17NO2S    FW 215.31
1
g
30.00
5
g
100.00
25
g
340.00

(+)-L-2,10-Camphorsultam, ≥98.5%
((1R)-2,10-Camphorsultam; (+)-exo-10,2-Bornanesultam; (1R,5S)-10,10-Dimethyl-3-thia-4-azatricyclo[5.2.1.01,5]decane 3,3-dioxide)
[108448-77-7]    C10H17NO2S    FW 215.31
1
g
30.00
5
g
100.00
25
g
340.00

(20S)-Camptothecin, ≥98%
[7689-03-4]    C20H16N2O4    FW 348.35

N,N′-Carbonyldiimidazole
[CDI]
[530-62-1]
25
g
40.00

S-Carboxymethyl-L-cysteine
((S)-2-Amino-3-(carboxymethylthio)propionic acid)
[638-23-3]    C6H11NO4S    FW 193.22

(R)-(+)-4-Chloro-3-hydroxybutyric acid ethyl ester, ≥97%, ≥98% e.e.
(Ethyl (R)-4-chloro-3-hydroxybutyrate)
[90866-33-4]    C6H11ClO3    FW 166.60    FP >230 ?F
1
g
32.00
5
g
110.00
25
g
325.00

(S)-(−)-4-Chloro-3-hydroxybutyric acid ethyl ester
(Ethyl (S)-4-chloro-3-hydroxybutyrate)
[86728-85-0]    C6H11ClO3    FW 166.60    FP 228 ?F (109 ?C)

(R)-(+)-4-Chloro-3-hydroxybutyric acid methyl ester
(Methyl (R)-4-chloro-3-hydroxybutyrate)
[88496-70-2]    C5H9ClO3    FW 152.58

(R)-1-(Chloromethyl)-5-methyl-2-pyrrolidinone
[154747-82-7]

(R)-(+)-4-(2-Chlorophenyl)-2-hydroxy-5,5-dimethyl-1,3,2-dioxaphosphorinane 2-oxide
[98674-87-4]    C11H14ClO4P    FW 276.65

(S)-(−)-4-(2-Chlorophenyl)-2-hydroxy-5,5-dimethyl-1,3,2-dioxaphosphorinane 2-oxide
[98674-86-3]    C11H14ClO4P    FW 276.65
Chiral phosphoric acid used for the resolution of amines, amino acids, and amino alcohols.
1
g
80.00

9-Chloro-9-phenylthioxanthene
C19H13ClS    FW 308.82
1
g
25.00
5
g
85.00
25
g
285.00

9-Chloro-9-phenylxanthene
[Pixyl chloride]
[42506-03-6]    C19H13ClO    FW 292.76
1
g
23.00
5
g
67.00
25
g
225.00

(R)-(−)-3-Chloro-1,2-propanediol
[57090-45-6]    C3H7ClO2    FW 110.54

(S)-(+)-3-Chloro-1,2-propanediol
[60827-45-4]    C3H7ClO2    FW 110.54

(−)-Cinchonidine
[485-71-2]    C19H22N2O    FW 294.39

Cinchonine
[118-10-5]    C19H22N2O    FW 294.39

m-Cyano-L-phenylalanine
((S)-2-Amino-3-(3-cyanophenyl)propanoic acid; (m-CN)Phe-OH)
[144799-02-0]    C10H10N2O2    FW 190.20

N-tBOC-m-Cyano-L-phenylalanine
((S)-2-(tert-Butoxycarbonylamino)-3-(3-cyanophenyl)propanoic acid)
[131980-30-8]    C15H18N2O4    FW 290.31

N-FMOC-m-Cyano-L-phenylalanine
((S)-2-(Fluorenylmethoxycarbonylamino)-3-(3-cyanophenyl)propanoic acid)
[205526-36-9]    C25H20N2O4    FW 412.44

p-Cyano-L-phenylalanine
((S)-2-Amino-3-(4-cyanophenyl)propanoic acid; (p-CN)Phe-OH)
[104531-20-6]    C10H10N2O2    FW 190.20

N-tBOC-p-Cyano-L-phenylalanine
((S)-2-(tert-Butoxycarbonylamino)-3-(4-cyanophenyl)propanoic acid)
[131724-45-3]    C15H18N2O4    FW 290.31

N-FMOC-p-Cyano-L-phenylalanine
((S)-2-(Fluorenylmethoxycarbonylamino)-3-(4-cyanophenyl)propanoic acid)
[173963-93-4]    C25H20N2O4    FW 412.44

(6R)-(−)-2-Cyano-6-phenyloxazolopiperidine
([3R-(3α,5β,8aα)]-Hexahydro-3-phenyl-5H-oxazolo[3,2-a]pyridine-5-carbonitrile)
[88056-92-2]    C14H16N2O    FW 228.29

(6S)-(+)-2-Cyano-6-phenyloxazolopiperidine
[106565-71-3]    C14H16N2O    FW 228.29

(R)-(+)-3-Cyclohexenecarboxylic acid
[5709-98-8]    C7H10O2    FW 126.15

(S)-(−)-3-Cyclohexenecarboxylic acid
[5708-19-0]    C7H10O2    FW 126.15

D-Cyclohexylglycine, ≥98%
((R)-(+)-2-Amino-2-cyclohexylacetic acid; D-Chg-OH)
[14328-52-0]    C8H15NO2
1
g
22.00
5
g
75.00
25
g
250.00

L-Cyclohexylglycine, ≥98%
((S)-2-Amino-2-cyclohexylacetic acid; L-Chg-OH)
[14328-51-9]    C8H15NO2
1
g
22.00
5
g
75.00
25
g
250.00

L-Cyclohexylglycine, methyl ester, hydrochloride

L-Cyclopentylglycine methyl ester hydrochloride, ≥98.0%
(Methyl (S)-2-Amino-2-cyclopentylacetate hydrochloride; Methyl (S)-α-aminocyclopentaneacetate hydrochloride; Cpg-OMe·HCl)
[14328-62-2]    C8H16ClNO2    FW 193.67

β-Cyclopropyl-L-alanine
C6H11NO2    FW 129.16

N-tBOC-β-Cyclopropyl-L-alanine
C11H19NO4    FW 229.27

N-FMOC-β-Cyclopropyl-L-alanine
[214750-76-2]    C21H21NO4    FW 351.40